Navigation Links
Trojan(R) Ranks U.S. Colleges and Universities in Second Annual Sexual Health Report Card
Date:9/10/2007

le (SWAY), continue to be highly rated; however, the school's lower ranking is a result of the expanded categories and schools considered. The 2007 Sexual Health Report Card examined 139 schools, nearly 50 percent more than last year, and judged several categories not taken into consideration last year, resulting in different rankings.

Highest- and Lowest-Ranked Schools

1. University of Minnesota (GPA 3.91)

2. University of Wyoming (GPA 3.91)

3. University of Washington (GPA 3.73)

4. Rutgers University (GPA 3.68)

5. Purdue University (GPA 3.64)

135. Villanova University (GPA 1.45)

136. University of Arkansas (GPA 1.36)

137. Arkansas State University (GPA 1.14)

138. University of Louisiana (GPA 0.91)

139. Louisiana Tech University (GPA 0.82)

For the first time, researchers allowed students to weigh in with an online survey that generated more than 3,300 responses. This opinion poll did not factor into the rankings, but does point to the opportunity for health centers on campus to evolve how they meet the needs of their students.

While 66 percent said their health centers are "doing a good job," 32 percent of respondents said they would not consider contacting their student health center for health concerns and 53 percent agreed their centers could improve overall.

"The fact is, college students are at serious risk for STIs and unplanned pregnancies," said Jim Daniels, vice president of marketing, Trojan brand condoms. "It's time to evolve the way we address the realities of sexual health and provide students with the practical resources they need to protect themselves. The Trojan Sexual Health Report Card helps students and their schools celebrate areas of excellence and focus on opportunities to improve."

Information was gathered over an eight-week period beginning in the spring of 2007, and was collected via live student health center phone interviews. This data was then corr
'/>"/>

SOURCE TROJAN(R)
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. Ontario Ranks Highest in Free Bird Flu Vaccination Rates
2. Orissa To Get New Medical Colleges Soon
3. Medical Colleges, Confident of Meeting Standards Before 90-days deadline
4. Controversy over Fees Structure in Private Medical Colleges
5. Controversy Over The Fee Structure In Private Medical Colleges Surfaces Yet Again
6. Maharashtra Medical And Dental Colleges Decide To Fix Own Fees
7. Approval Given for Two Medical Colleges In Karnataka
8. High Court Stops Functioning of Ayurvedic, Unani Colleges in Uttar Pradesh
9. Anti-AIDS Plan for 1,000 Tamil Nadu Colleges
10. Haryana to set up Red Ribbon Clubs in Colleges to Create Awareness about AIDS
11. Bihar to get eight new private medical colleges
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 2Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 3Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 5Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 6Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 7Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 8Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 9Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 10BioCryst Provides Update Regarding Peramivir for Influenza 5116 1BioCryst Provides Update Regarding Peramivir for Influenza 5116 2BioCryst Provides Update Regarding Peramivir for Influenza 5116 3BioCryst Provides Update Regarding Peramivir for Influenza 5116 4BioCryst Provides Update Regarding Peramivir for Influenza 5116 5Study explores how life experiences contribute to the biological changes of Alzheimers 10197 1Study explores how life experiences contribute to the biological changes of Alzheimers 10197 2Study explores how life experiences contribute to the biological changes of Alzheimers 10197 3Doctor Visits Are Getting Short Shrift in Tight Economy 58589 1Doctor Visits Are Getting Short Shrift in Tight Economy 58589 2